Trailing-twelve-month (TTM) revenue is $317.65 Million with a year-over-year growth of +9.98%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $75,311,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-29 |
| Q4 FY2025Period ended 2025-12-31 | $80,245,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-11 |
| Q1 FY2026Period ended 2026-03-31 | $79,813,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-30 | $82,280,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-29 |
| TTM revenue | $317,649,000 |
Current P/S: $1,323,430,202 market capitalization ÷ $317,649,000 TTM revenue = 4.17x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T18:10:19.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $82.28M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T18:13:50.583Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|
| Products | $172M | $146M | $155M | $190M |
| Services | $121M | $116M | $119M | $112M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20162016-12-31 · USD | FY20172017-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| America - other | $17M | $19M | $30M | $30M | $34M | $32M |
| Asia Pacific | $58M | $57M | $65M | $61M |
$317.65M
$317.65 Million
+9.98%
vs. $288.82M a year ago (TTM)
+3.46%
5 Year compound annual growth rate
1 Year
+9.98%
3 Year
+4.39%
5 Year
+3.46%
10 Year
+4.67%
15 Year
+4.87%
20 Year
+7.13%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $301.85M | +$26.97M | +9.81% |
| 2024 | $274.88M | +$13.59M | +5.20% |
| 2023 | $261.29M | ($32.13M) | (10.95%) |
| 2022 | $293.43M | +$6.93M | +2.42% |
| 2021 | $286.50M | +$36.47M | +14.59% |
| 2020 |
TTM Growth
+9.98%
3-Year CAGR
+4.39%
5-Year CAGR
+3.46%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T18:13:50.583Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $66M |
| EMEA | $54M | $57M | N/A | N/A | N/A | N/A |
|---|
| Europe Middle East Africa | N/A | N/A | $104M | $96M | $94M | $111M |
|---|
| The United States | $68M | $78M | $94M | $73M | $83M | N/A |
|---|
| UNITED STATES | N/A | N/A | N/A | N/A | N/A | $93M |
|---|
| $250.03M |
| ($2.04M) |
| (0.81%) |
| 2019 | $252.07M | +$17.67M | +7.54% |
| 2018 | $234.40M | +$23.04M | +10.90% |
| 2017 | $211.37M | +$14.78M | +7.52% |
| 2016 | $196.59M | ($19.98M) | (9.23%) |
